Skip to main content
Clinical Trials/NCT05014893
NCT05014893
Recruiting
N/A

Neural Mechanisms of Cognitive Assessment and Rehabilitation for Cognitive Decline

National Research Center for Rehabilitation Technical Aids1 site in 1 country100 target enrollmentAugust 6, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Mild Cognitive Impairment (MCI)
Sponsor
National Research Center for Rehabilitation Technical Aids
Enrollment
100
Locations
1
Primary Endpoint
Change in Cognitive function (MoCA)
Status
Recruiting
Last Updated
11 months ago

Overview

Brief Summary

This study investigates the neural mechanisms of cognitive function decline, cognitive assessment methods for subjects with mild cognitive dysfunction (Mild cognitive impairment, MCI, or cognitive decline milder than MCI), and the approaches used to improve and restore cognitive function.

Detailed Description

Cognitive assessment tools are used to assess cognitive function of subjects in different cities. Functional and structural MRI and EEG are applied to investigate the neural mechanisms of cognitive function decline and effects of methods to improve and restore cognitive function.

Registry
clinicaltrials.gov
Start Date
August 6, 2021
End Date
December 31, 2026
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
National Research Center for Rehabilitation Technical Aids
Responsible Party
Principal Investigator
Principal Investigator

Pengxu Wei

Director

National Research Center for Rehabilitation Technical Aids

Eligibility Criteria

Inclusion Criteria

  • Adults being able to walk at least a block, and
  • Adults with subjective cognitive decline (SCD), or
  • Adults with mild cognitive impairment (MCI), or
  • Adults with normal cognitive function

Exclusion Criteria

  • Clinical diagnosis of dementia
  • Adults who cannot follow the protocal

Outcomes

Primary Outcomes

Change in Cognitive function (MoCA)

Time Frame: Change from Baseline Cognitive test results at 3 months.

The Montreal Cognitive Assessment test is used to assess cognitive function of participants.

Change in Cognitive function (AD8)

Time Frame: Change from Baseline Cognitive test results at 3 months.

The AD8 test is used to assess cognitive function of participants.

Change in Cognitive function (CDR)

Time Frame: Change from Baseline Cognitive test results at 3 months.

The Clinical Dementia Rating (CDR) test is used to assess cognitive function of participants.

Change in Cognitive function (SCD-9)

Time Frame: Change from Baseline Cognitive test results at 3 months.

The SCD-9 questionnaire is used to assess cognitive function of participants.

Secondary Outcomes

  • Change in Physical capacity (TUG)(Change from Baseline physical capacity test results at 3 months.)
  • Change in Physical capacity (chair standing)(Change from Baseline physical capacity test results at 3 months.)

Study Sites (1)

Loading locations...

Similar Trials